在遗传性出血性角膜切除症中FVIII水平升高:对临床管理的影响
Ole Jakob Jørgensen1, Johan Edvard Steineger1, Andreas Hillarp2,3
1Department of Otorhinolaryngology & Head and Neck Surgery Oslo University Hospital, Medical Faculty, University of Oslo Oslo Norway.
Laryngoscope investigative otolaryngology
|February 16, 2024
概括
血栓塞栓事件在挪威遗传性出血性长膜炎 (HHT) 患者中很常见,高的第八因子 (FVIII) 水平显著增加了风险. 建议进行重复的FVIII测量,以准确评估HHT的风险.
科学领域:
- 血液学 血液学 血液学
- 血管医学 血管医学
- 遗传学 遗传学 是一个
背景情况:
- 遗传性出血性长膜炎 (HHT) 是一种影响血管的遗传性疾病.
- 血栓塞栓事件 (动脉和静脉) 是HHT的已知并发症.
- 特定的凝血因子,如FVIII在与HHT相关的血栓栓塞的作用需要进一步研究.
研究的目的:
- 在挪威HHT人口中确定动脉和静脉血栓栓塞事件的流行率.
- 探索与这些事件相关的潜在因素,重点关注第八因子 (FVIII) 水平.
主要方法:
- 研究了134名挪威HHT患者的队列.
- 收集了病史,重点关注血栓栓塞事件.
- 血液样本分析了FVIII,FIX,vWF,血红蛋白,铁,费里丁和CRP.
主要成果:
- 血栓塞栓事件的总体患病率为23.1%.
- 在68.3%的患者中发现FVIII水平升高 (>150 IU/dL),与血栓栓塞事件显著相关 (p < .001).
- 在25%的重复测量患者中,FVIII水平呈现波动.
结论:
- 血栓塞栓事件在挪威HHT人口中非常普遍.
- 高FVIII水平和年龄是HHT中血栓栓塞事件的重要风险因素.
- 由于FVIII水平的波动,序列测量对于评估HHT患者的血栓栓塞风险至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Esophageal Varices-II: Clinical Features and Management
67
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
67
Disorders of Hemostasis
906
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
906
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Coagulation
6.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.6K


